| __timestamp | Merck & Co., Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 16768000000 | 125883000 |
| Thursday, January 1, 2015 | 14934000000 | 69036000 |
| Friday, January 1, 2016 | 13891000000 | 72700000 |
| Sunday, January 1, 2017 | 12775000000 | 105700000 |
| Monday, January 1, 2018 | 13509000000 | 198700000 |
| Tuesday, January 1, 2019 | 14112000000 | 117600000 |
| Wednesday, January 1, 2020 | 13618000000 | 108100000 |
| Friday, January 1, 2021 | 13626000000 | 122500000 |
| Saturday, January 1, 2022 | 17411000000 | 146700000 |
| Sunday, January 1, 2023 | 16126000000 | 257500000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, cost efficiency is a critical metric for success. Over the past decade, Merck & Co., Inc. and United Therapeutics Corporation have demonstrated contrasting trends in their cost of revenue. From 2014 to 2023, Merck's cost of revenue fluctuated, peaking in 2022 with a 27% increase from its lowest point in 2017. Meanwhile, United Therapeutics showcased a more volatile pattern, with a significant 104% rise in 2023 compared to 2015. This stark contrast highlights Merck's relatively stable cost management compared to United Therapeutics' dynamic shifts. As the industry faces increasing pressure to optimize costs, these insights provide a window into the strategic approaches of two leading pharmaceutical companies. Understanding these trends is crucial for investors and stakeholders aiming to navigate the complexities of the healthcare market.
Johnson & Johnson vs Merck & Co., Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: AbbVie Inc. vs United Therapeutics Corporation
Merck & Co., Inc. vs Zoetis Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Merck & Co., Inc. and Intra-Cellular Therapies, Inc.
Analyzing Cost of Revenue: Merck & Co., Inc. and Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Merck & Co., Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Merck & Co., Inc. vs MorphoSys AG
Cost of Revenue Trends: Pfizer Inc. vs United Therapeutics Corporation
Teva Pharmaceutical Industries Limited vs United Therapeutics Corporation: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for United Therapeutics Corporation and BioCryst Pharmaceuticals, Inc.